Orthofix Medical Inc. (OFIX) vs REGENXBIO Inc. (RGNX)

A side-by-side comparison of Orthofix Medical Inc. and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OFIX vs RGNX

growth of $100 · dividends reinvested · last 10y
OFIX -77.1% (-13.7%/yr)RGNX -52.1% (-7.1%/yr)RGNX compounded faster over this window
0100200300400500Start $10020182020202220242026$23$48
OFIX RGNX

OFIX vs RGNX: by the numbers

  • •RGNX is the larger company ($390M vs $387M market cap).
  • •Both run net losses; OFIX's is the smaller (-7.41% vs -112.58% net margin).
  • •OFIX grew revenue faster over the past five years (12.83% vs 1.59% CAGR).

Metrics side by side

Valuation

MetricOFIXRGNX
P/S ratio0.462.24
P/B ratio0.905.44
EV / EBITDA4.33N/A

Profitability

MetricOFIXRGNX
Gross margin69.59%88.09%
Operating margin-3.05%-94.08%
Net margin-7.41%-112.58%
ROE-14.38%-273.72%
ROIC-3.55%-54.00%

Growth (annualized)

MetricOFIXRGNX
Revenue CAGR (5Y)12.83%1.59%
Total return CAGR (5Y)-23.97%-24.15%

Frequently asked

Which has grown faster, OFIX or RGNX?
Over the past five years, OFIX grew revenue faster — OFIX at a 12.83% CAGR versus RGNX at 1.59%.
How have OFIX and RGNX total returns compared?
Over the past 10 years, OFIX delivered -13.51% and RGNX delivered -6.47% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.